Oxygen4Life

Oxygen4Life

Early Stage

Biomedicine company

Biomedicine company

Overview

Raised to Date: Raised: $91,630

Total Commitments ($USD)

Platform

Dealmaker Securities

Start Date

01/12/2023

Close Date

01/10/2024

Min. Goal
$10,000
Max. Goal
$500,400
Min. Investment

$100

Security Type

Equity - Common

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$0.60

Pre-Money Valuation

$5,000,000

Rolling Commitments ($USD)

Status
Funded
Reporting Date

01/30/2024

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$253

# of Investors

69

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2022

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2C

Margin

Low

Capital Intensity

Low

Location

Sheridan, Wyoming

Business Type

Growth

Oxygen4Life, with a valuation of $5 million, is raising funds on Dealmaker Securities. It is a biomedicine company that leverages its partnerships with patents for people suffering from an impaired delta-6 desaturase metabolic pathway. The medical food of Oxygen4Life, EXtrek, manages diseases including cardiovascular disease, diabetes, neuropathy, IBS, fatty liver, and more. Mike Maunu founded Oxygen4Life in February 2022. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $500,400. The campaign proceeds will be used for marketing, solutions enhancement, operations, and hiring.

Summary Profit and Loss Statement

FY 2021 FY 2020

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$0

$0

Summary Balance Sheet

FY 2021 FY 2020

Cash

$41

$0

Accounts Receivable

$0

$0

Total Assets

$41

$0

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Financials as of: 01/12/2023
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Oxygen4Life on DealMaker Securities 2023
Platform: Dealmaker Securities
Security Type: Equity - Common
Valuation: $5,000,000
Price per Share: $0.60

Follow company

Follow Oxygen4Life on DealMaker Securities 2023

Buy Oxygen4Life's Deal Report

Warning: according to the close date for this deal, Oxygen4Life may no longer be accepting investments.

Oxygen4Life Deal Report

Get KingsCrowd’s comprehensive report on Oxygen4Life including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Oxygen4Life is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Oxygen4Life deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge